Terms ending in 2042
Every in-force patent on Vantis Vascular, Inc.'s record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,759,315 | Method and Apparatus for Antegrade Transcatheter Valve Repair or Implantation In force · High confidence | Vantis Vascular, Inc. | In force | High confidence | |
| US 11,766,328 | Method and Apparatus for Antegrade Transcatheter Valve Repair or Implantation In force · High confidence | Vantis Vascular, Inc. | In force | High confidence | |
| US 11,925,554 | Method and Apparatus for Antegrade Transcatheter Valve Repair or Implantation In force · High confidence | Vantis Vascular, Inc. | In force | High confidence | |
| US 12,186,189 | Method and Apparatus for Antegrade Transcatheter Valve Repair or Implantation In force · High confidence | Vantis Vascular, Inc. | In force | High confidence | |
| US 12,390,328 | Method and Apparatus for Antegrade Transcatheter Valve Repair or Implantation In force · High confidence | Vantis Vascular, Inc. | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.